- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/74 - Oxygen atoms
Patent holdings for IPC class C07D 211/74
Total number of patents in this class: 107
10-year publication summary
8
|
4
|
4
|
12
|
9
|
6
|
11
|
3
|
3
|
10
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
OP Bio Factory Co., Ltd. | 14 |
6 |
Seed Research Institute Co., Ltd. | 12 |
6 |
BASF SE | 21017 |
5 |
Cassava Science, Inc. | 13 |
5 |
Nitto Denko Corporation | 8338 |
4 |
Merck Patent GmbH | 5767 |
3 |
University of Florida Research Foundation, Inc. | 4053 |
3 |
Evonik Operations GmbH | 4174 |
3 |
HK Inno.n Corporation | 109 |
3 |
Novartis AG | 10721 |
2 |
California Institute of Technology | 3984 |
2 |
The Regents of the University of Michigan | 4751 |
2 |
The Johns Hopkins University | 5714 |
2 |
Abbvie Inc. | 1806 |
2 |
Zhejiang Ausun Pharmaceutical Co., Ltd. | 37 |
2 |
Hangzhou Yirui Pharmaceutical Technology Co., Ltd | 5 |
2 |
Molecure Spółka Akcyjna | 20 |
2 |
Glaxo Group Limited | 4122 |
1 |
Bristol-myers Squibb Company | 4849 |
1 |
LG Chem, Ltd. | 17676 |
1 |
Other owners | 50 |